Skip to main content
. 2022 Jul 6;10(7):e005025. doi: 10.1136/jitc-2022-005025

Table 1.

Marker AQUA scores by clinicopathologic variable

Cohort 1 (N=379) Cohort 2 (N=247)
Marker CD11b CD68 HLA-DR N CD11b CD68 HLA-DR N
Age
 <65 29,798 p=0.23 3672 p=0.75 17,699 p=0.04 157 17,334 p=0.27 13,224 p=0.92 7215 p=0.70 115
 >65 32,793 3720 16,052 211 18,075 1415 8180 132
Gender
 Male 33,100 p=0.04 3720 p=0.84 17,231 p=0.76 173 17,999 p=0.28 1420 p=0.13 8049 p=0.42 196
 Female 29,870 3672 17,086 199 16,557 1140 7842 31
Histology
 ADC 32,987 p=0.0001 3840 p=0.008 17,247 p>0.99 202 18,905 p=0.0002 1505 p=0.22 8728 p=0.10 87
 SCC 51,473 4766 17,288 86 28,003 1813 10,009 111
 Other 36,230 3683 15,053 72 20,767 1253 7764 30
Smoking
 Ever smoker 32,387 p=0.09 3815 p=0.05 16,836 p=0.83 296 17,897 p=0.77 1422 p=0.72 8160 p=0.62 183
 Never smoker 28,103 3135 17,228 44 19,449 1390 8485 19
Stage
 I–II 32,527 p=0.74 3797 p=0.59 17,482 p=0.16 279 19,763 p=0.97 1591 p=0.95 10,483 p=0.82 136
 III–IV 31,667 3537 17,057 72 22,453 1749 9524 87

ADC, adenocarcinomas; SCC, squamous cell carcinomas.